Kai-Cheng Hsu: How polygenic scores can enhance disease prediction
Kai-Cheng Hsu shared a post on LinkedIn:
“I am thrilled to announce that our groundbreaking research on the ‘Utility of polygenic scores across diverse diseases in a hospital cohort for predictive modeling’ has been published in *Nature Communications*! This pioneering study unlocks potential in precision medicine by showcasing how polygenic scores can dramatically enhance disease prediction and patient care strategies. A true milestone for our team, this publication underscores our commitment to revolutionizing healthcare through science.”
Read further.
Source: Kai-Cheng Hsu/LinkedIn
Kai-Cheng Hsu is the Chief Medical Officer of Biomedical Technology and Device Research Laboratories in Industrial Technology Research Institute (ITRI). His areas of research interest include the applications of artificial intelligence in medical images, biomedical signals, electronic health records, and bioinformatics. His goal is to combine his expertise in medicine and engineering to apply AI to develop products for advancing biomedical technology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023